Timolol 0.5% Ophthalmic Solution

DRUG6 trials

Sponsors

Alcon Research, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Ohio State University, University of California, Davis, Pham Ngoc Thach University of Medicine

Conditions

Acne VulgarisErythemaExcision MarginGlaucomaMohs Micrographic SurgeryOHT - Ocular HypertensionOcular HypertensionOpen-Angle Glaucoma

Early Phase 1

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

RecruitingNCT07474883

Pham Ngoc Thach University of MedicineAcne Vulgaris, Erythema, Post Inflammtory Erythema

Start: 2026-03-09End: 2026-10-09Target: 60Updated: 2026-04-01

Phase 2

Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing

Not yet recruitingNCT07384767

University of California, DavisExcision Margin, Mohs Micrographic Surgery

Start: 2026-06-01End: 2027-12-31Target: 220Updated: 2026-02-09

Phase 3

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT00293800

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2004-07-31End: 2005-12-31Updated: 2012-02-14

A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients

CompletedNCT00856622

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Glaucoma, Ocular Hypertension, Open-angle Glaucoma

Start: 1997-08-31End: 1999-06-30Updated: 2021-02-21

Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT01357616

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2010-11-30End: 2013-01-31Updated: 2014-04-10

Phase 4

Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance

CompletedNCT04412096

Ohio State UniversityGlaucoma, OHT - Ocular Hypertension

Start: 2020-11-23End: 2025-05-22Updated: 2026-03-04